CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0320
-0.0023 (-6.71%)
At close: Apr 27, 2026

CERO Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.593.251.520.481.1
Cash & Short-Term Investments
1.593.251.520.481.1
Cash Growth
-51.19%113.76%219.73%-56.68%-
Prepaid Expenses
1.070.270.370.230.26
Restricted Cash
0.070.070.0841.67-
Other Current Assets
-0.11---
Total Current Assets
2.733.711.9742.371.36
Property, Plant & Equipment
0.911.993.16--
Long-Term Deferred Tax Assets
----0.02
Long-Term Deferred Charges
-0.5---
Other Long-Term Assets
----178.7
Total Assets
3.646.215.1342.37180.08
Accounts Payable
7.584.511.671.650.01
Accrued Expenses
0.71.910.1400.08
Short-Term Debt
--0.60.65-
Current Portion of Leases
0.70.880.77--
Current Income Taxes Payable
---0.6-
Other Current Liabilities
0.110.110.3227.84-
Total Current Liabilities
9.097.43.5130.750.1
Long-Term Leases
-0.71.58--
Other Long-Term Liabilities
---22.62187.65
Total Liabilities
9.098.15.0853.37187.75
Common Stock
00000
Additional Paid-In Capital
78.1367.141.03--
Retained Earnings
-90.84-70.92-43.09-11-7.67
Comprehensive Income & Other
--1.3---
Total Common Equity
-12.71-5.07-42.06-11-7.67
Shareholders' Equity
-5.45-1.890.04-11-7.67
Total Liabilities & Equity
3.646.215.1342.37180.08
Total Debt
0.71.582.940.65-
Net Cash (Debt)
0.891.68-1.42-0.171.1
Net Cash Growth
-47.01%----
Net Cash Per Share
0.2165.72--15.48-
Filing Date Shares Outstanding
36.790.27--0.01
Total Common Shares Outstanding
21.10.12--0.01
Working Capital
-6.35-3.69-1.5411.621.26
Book Value Per Share
-0.60-41.98---667.47
Tangible Book Value
-12.71-5.07-42.06-11-7.67
Tangible Book Value Per Share
-0.60-41.98---667.47
Machinery
2.552.552.55--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.